World Health Organization

---

A global cross-sectoral approach is required to address the threat of antimicrobial resistance (AMR).

The Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE), and the World Health Organization (WHO) work collaboratively as a tripartite with the aim of tackling AMR through a One Health approach. They support countries to develop and implement National Action Plans (NAPs) on AMR.

Since 2016 the Fleming Fund has provided funding to the FAO to tackle AMR as part of a joint proposal for funding from the Tripartite. Funding has been used to: support countries to develop and implement NAPs, develop global guidance and protocols on AMR and antimicrobial Consumption (AMC), support the establishment of effective AMR governance systems, increase the technical capacity of countries, raise awareness of AMR and change behaviours in targeted sectors, and support effective collaboration across the Tripartite.

This work creates the enabling environment for the generation, sharing, and use of AMR surveillance data and directly supports the implementation of the Fleming Fund country grants programme.

Partners:

World Health Organization (WHO)

Timeline:

August 2016 - March 2020

Value:

£9.9m

Priority countries:

Countries across the WHO AFRO, WPRO, SEARO and EMRO regions.

Objectives

• to support the development and implementation of NAPs on AMR that are aligned with the global action plan on AMR and with standards and guidelines established by the intergovernmental bodies such as the Codex Alimentarius Commission, FAO and OIE
• to support integrated surveillance and reporting of AMR in human and animal health and agriculture
• to collect, consolidate and publish information on the global consumption of antimicrobial medicines, and enhance the capacity to gather data on consumption and use of antibiotics in low- and middle-income countries (LMICs)

Activities

• countries supported to develop and implement multi-sectoral NAPs through support from country and regional offices including provision of workshops
• countries trained and supported to undertake AMR use and consumption studies and to share this data through global reports
• piloting of the Tricycle One Health AMR surveillance protocol supporting the collection of AMR data in humans, poultry, and the environment
• expansion of the Tricycle protocol to include guidance on data collection of the presence of antimicrobial agents in the environment, especially in water, wastewater and food
• AWaRe categorisation and EML updated additional syndromes, antibiotics and classes. Redesign of EML as an interactive app to make it easier for policy makers and prescribers to access